1. Merck leaps into COVID vaccine race — Evofem Biosciences gets FDA approval for new non-hormonal contraceptive — Sanofi sells $13 billion stake in Regeneron — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Omeros

Discussion in 'Ophthalmology' started by Anonymous, Jun 23, 2014 at 8:49 AM.

Tags: Edit
  1. Anonymous

    Anonymous Guest

    Whats up with this company? I rec'd a call from a recruiter that they were all hot to trot getting someone to Dallas for an interview. She said that they were looking for ophtho experience but when it came down to it they did not pay for any experience. I hope for those that did get an interview, that this company understands that w/o ophtho exp. they will be getting started on the wrong foot. Can you say "one trick pony".
     

  2. Anonymous

    Anonymous Guest

    Be very careful of this potential train wreck. You heard it hear 1st!
     
  3. Anonymous

    Anonymous Guest

    I'm on this wreck, and I might agree.
     
  4. anonymous

    anonymous Guest

    Well, well, well[​IMG]
     
  5. anonymous

    anonymous Guest

    People are now quitting without jobs...